• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化寡转移性结直肠癌的局部区域管理:技术层面与生物标志物,同一硬币的两面

Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin.

作者信息

Mauri Giovanni, Monfardini Lorenzo, Garnero Andrea, Zampino Maria Giulia, Orsi Franco, Della Vigna Paolo, Bonomo Guido, Varano Gianluca Maria, Busso Marco, Gazzera Carlo, Fonio Paolo, Veltri Andrea, Calandri Marco

机构信息

Divisione di Radiologia Interventistica, Istituto Europeo di Oncologia, IRCCS, 20141 Milan, Italy.

Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano, 20122 Milan, Italy.

出版信息

Cancers (Basel). 2021 May 26;13(11):2617. doi: 10.3390/cancers13112617.

DOI:10.3390/cancers13112617
PMID:34073585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8198296/
Abstract

Colorectal cancer (CRC) is the third most common cancer worldwide and has a high rate of metastatic disease which is the main cause of CRC-related death. Oligometastatic disease is a clinical condition recently included in ESMO guidelines that can benefit from a more aggressive locoregional approach. This review focuses the attention on colorectal liver metastases (CRLM) and highlights recommendations and therapeutic locoregional strategies drawn from the current literature and consensus conferences. The different percutaneous therapies (radiofrequency ablation, microwave ablation, irreversible electroporation) as well as trans-arterial approaches (chemoembolization and radioembolization) are discussed. Ablation margins, the choice of the imaging guidance as well as characteristics of the different ablation techniques and other technical aspects are analyzed. A specific attention is then paid to the increasing role of biomarkers (in particular molecular profiling) and their role in the selection of the proper treatment for the right patient. In conclusion, in this review an up-to-date state of the art of the application of locoregional treatments on CRLM is provided, highlighting both technical aspects and the role of biomarkers, two sides of the same coin.

摘要

结直肠癌(CRC)是全球第三大常见癌症,其转移性疾病发生率很高,这是CRC相关死亡的主要原因。寡转移性疾病是一种最近被纳入欧洲肿瘤内科学会(ESMO)指南的临床情况,可从更积极的局部区域治疗方法中获益。本综述将重点关注结直肠癌肝转移(CRLM),并强调从当前文献和共识会议中得出的建议及局部区域治疗策略。文中讨论了不同的经皮治疗方法(射频消融、微波消融、不可逆电穿孔)以及经动脉治疗方法(化疗栓塞和放射性栓塞)。分析了消融边缘、成像引导的选择以及不同消融技术的特点和其他技术方面。随后特别关注生物标志物(尤其是分子谱分析)日益增加的作用及其在为合适的患者选择合适治疗方法中的作用。总之,本综述提供了CRLM局部区域治疗应用的最新技术水平,突出了技术方面和生物标志物的作用,这两者是同一事物的两个方面。

相似文献

1
Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin.优化寡转移性结直肠癌的局部区域管理:技术层面与生物标志物,同一硬币的两面
Cancers (Basel). 2021 May 26;13(11):2617. doi: 10.3390/cancers13112617.
2
Oligometastatic Colorectal Cancer Management: A Survey of the Italian College of Interventional Radiology.寡转移结直肠癌的管理:意大利介入放射学学会的一项调查。
Cardiovasc Intervent Radiol. 2020 Oct;43(10):1474-1483. doi: 10.1007/s00270-020-02516-3. Epub 2020 May 24.
3
The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives.结直肠癌寡转移瘤的治疗:现状策略与未来展望。
Crit Rev Oncol Hematol. 2023 Jun;186:103990. doi: 10.1016/j.critrevonc.2023.103990. Epub 2023 Apr 13.
4
Multimodal Management of Colorectal Liver Metastases: State of the Art.结直肠癌肝转移的多模式管理:最新进展
Oncol Rev. 2024 Jan 4;17:11799. doi: 10.3389/or.2023.11799. eCollection 2023.
5
Oligometastatic Disease in Colorectal Cancer - How to Proceed?结直肠癌寡转移疾病——如何应对?
Visc Med. 2017 Mar;33(1):23-28. doi: 10.1159/000454688. Epub 2017 Feb 3.
6
The role of image-guided therapy in the management of colorectal cancer metastatic disease.影像引导治疗在结直肠癌转移性疾病管理中的作用。
Eur J Cancer. 2017 Apr;75:231-242. doi: 10.1016/j.ejca.2017.01.010. Epub 2017 Feb 24.
7
The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease.经皮消融在结直肠癌肝转移疾病管理中的作用
Diagnostics (Basel). 2021 Feb 14;11(2):308. doi: 10.3390/diagnostics11020308.
8
New Perspectives in the Treatment of Colorectal Metastases.结直肠癌转移治疗的新视角
Liver Cancer. 2016 Nov;6(1):90-98. doi: 10.1159/000449492. Epub 2016 Nov 29.
9
Thermal ablation in the management of oligometastatic colorectal cancer.热消融治疗寡转移结直肠癌。
Int J Hyperthermia. 2022;39(1):627-632. doi: 10.1080/02656736.2021.1941311.
10
New Developments in Interventional Oncology: Liver Metastases From Colorectal Cancer.介入肿瘤学的新进展:结直肠癌肝转移
Cancer J. 2016 Nov-Dec;22(6):373-380. doi: 10.1097/PPO.0000000000000226.

引用本文的文献

1
Technical aspects, methodological challenges, and factors predicting outcomes of percutaneous ablation for colorectal liver metastases.结直肠癌肝转移经皮消融的技术层面、方法学挑战及预测预后的因素
Pol J Radiol. 2025 May 30;90:e279-e285. doi: 10.5114/pjr/204158. eCollection 2025.
2
Decision-Making for Ablation of Colorectal Liver Oligometastases Patients: A 10-Year Retrospective Study of Survival Outcomes Based on Right-Versus Left-Sided Primary Tumor Location.结直肠癌肝寡转移患者消融治疗的决策:基于原发肿瘤位于右侧与左侧的10年生存结局回顾性研究
Cancer Control. 2025 Jan-Dec;32:10732748251324627. doi: 10.1177/10732748251324627. Epub 2025 Mar 14.
3
Early Recurrence of Colorectal Liver Metastasis (Number ≤ 5 and Largest Diameter ≤ 3 cm) after Resection or Thermal Ablation: a Multi-center Study of Patterns, Safety, Survival and Risk Factors.结直肠癌肝转移灶切除或热消融术后早期复发(数量≤5个且最大直径≤3 cm):一项关于复发模式、安全性、生存率及危险因素的多中心研究
J Gastrointest Cancer. 2025 Mar 12;56(1):77. doi: 10.1007/s12029-025-01200-4.
4
Patterns and Predictors of Recurrence After Curative Resection of Colorectal Liver Metastasis (CRLM).结直肠肝转移(CRLM)根治性切除术后复发的模式和预测因素。
J Gastrointest Cancer. 2024 Dec;55(4):1559-1568. doi: 10.1007/s12029-024-01105-8. Epub 2024 Aug 22.
5
Predictive Factors for Local Recurrence after Intraoperative Microwave Ablation for Colorectal Liver Metastases.结直肠癌肝转移术中微波消融术后局部复发的预测因素
Cancers (Basel). 2022 Dec 25;15(1):122. doi: 10.3390/cancers15010122.

本文引用的文献

1
Recommendations for standards of monitoring during anaesthesia and recovery 2021: Guideline from the Association of Anaesthetists.麻醉监测和复苏期间监测标准推荐 2021:麻醉师协会指南。
Anaesthesia. 2021 Sep;76(9):1212-1223. doi: 10.1111/anae.15501. Epub 2021 May 20.
2
Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.不可逆电穿孔治疗不可切除结直肠癌肝转移(COLDFIRE-2):一项 II 期、两中心、单臂临床试验。
Radiology. 2021 May;299(2):470-480. doi: 10.1148/radiol.2021203089. Epub 2021 Mar 16.
3
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.个体化与标准剂量测定法在局部进展期肝细胞癌患者选择性内放射治疗中的应用(DOSISPHERE-01):一项随机、多中心、开放标签的 2 期试验。
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. doi: 10.1016/S2468-1253(20)30290-9. Epub 2020 Nov 7.
4
Oligometastatic Colorectal Cancer Management: A Survey of the Italian College of Interventional Radiology.寡转移结直肠癌的管理:意大利介入放射学学会的一项调查。
Cardiovasc Intervent Radiol. 2020 Oct;43(10):1474-1483. doi: 10.1007/s00270-020-02516-3. Epub 2020 May 24.
5
Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.液体活检:肿瘤学的范式转变:介入放射科医生应该知道什么。
Eur Radiol. 2020 Aug;30(8):4496-4503. doi: 10.1007/s00330-020-06700-4. Epub 2020 Mar 19.
6
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.液体活检与组织活检在检测胃肠道癌获得性耐药及肿瘤异质性中的应用。
Nat Med. 2019 Sep;25(9):1415-1421. doi: 10.1038/s41591-019-0561-9. Epub 2019 Sep 9.
7
Tailoring ablation strategies for colorectal liver metastases based upon rat sarcoma viral oncogene mutation status.根据大鼠肉瘤病毒致癌基因突变状态制定结直肠癌肝转移的消融策略。
Chin Clin Oncol. 2019 Oct;8(5):51. doi: 10.21037/cco.2019.08.05. Epub 2019 Sep 6.
8
Propofol Compared to Midazolam Sedation and to General Anesthesia for Percutaneous Microwave Ablation in Patients with Hepatic Malignancies: A Single-Center Comparative Analysis of Three Historical Cohorts.丙泊酚与咪达唑仑镇静及全身麻醉用于肝恶性肿瘤经皮微波消融术的比较:三个历史队列的单中心比较分析。
Cardiovasc Intervent Radiol. 2019 Nov;42(11):1597-1608. doi: 10.1007/s00270-019-02273-y. Epub 2019 Jun 26.
9
Fluorescent Tissue Assessment of Colorectal Cancer Liver Metastases Ablation Zone: A Potential Real-Time Biomarker of Complete Tumor Ablation.结直肠癌肝转移消融灶荧光组织评估:完全肿瘤消融的潜在实时生物标志物
Ann Surg Oncol. 2019 Jun;26(6):1833-1840. doi: 10.1245/s10434-018-07133-6. Epub 2019 Mar 4.
10
Adjunctive Thermoprotection During Percutaneous Thermal Ablation Procedures: Review of Current Techniques.经皮热消融手术中的辅助热保护:当前技术综述
Cardiovasc Intervent Radiol. 2019 Mar;42(3):344-357. doi: 10.1007/s00270-018-2089-7. Epub 2018 Oct 11.